Daniéla Rusu

694 total citations
15 papers, 213 citations indexed

About

Daniéla Rusu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniéla Rusu has authored 15 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniéla Rusu's work include Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Medical Imaging Techniques and Applications (3 papers). Daniéla Rusu is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Medical Imaging Techniques and Applications (3 papers). Daniéla Rusu collaborates with scholars based in France, Austria and Italy. Daniéla Rusu's co-authors include Caroline Rousseau, Françoise Kraeber‐Bodéré, Olivier Morel, L. Campion, Bogdan Catargi, Pierre Véra, Sophie Leboulleux, Ludovic Ferrer, Slimane Zerdoud and Marie‐Elisabeth Toubert and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Daniéla Rusu

14 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniéla Rusu France	8	108	86	82	71	18	15	213
S. Matschnig Austria	8	185 1.7×	140 1.6×	86 1.0×	89 1.3×	23 1.3×	8	294
Alexis Vrachimis Switzerland	8	133 1.2×	92 1.1×	34 0.4×	51 0.7×	37 2.1×	13	211
Samaneh Motanagh United States	7	31 0.3×	24 0.3×	30 0.4×	68 1.0×	20 1.1×	15	144
Gloria Rossi Italy	7	182 1.7×	163 1.9×	81 1.0×	41 0.6×	10 0.6×	14	300
A Arlandini Italy	10	204 1.9×	61 0.7×	159 1.9×	62 0.9×	39 2.2×	15	302
Kim Taubman Australia	9	24 0.2×	84 1.0×	32 0.4×	119 1.7×	19 1.1×	29	183
Ha Kyoung Park South Korea	10	273 2.5×	54 0.6×	238 2.9×	18 0.3×	19 1.1×	34	324
Iris Gomez Austria	9	300 2.8×	138 1.6×	174 2.1×	59 0.8×	24 1.3×	16	383
Stéphane Bardet France	9	312 2.9×	64 0.7×	227 2.8×	21 0.3×	15 0.8×	17	358
Shari Moreau United States	9	248 2.3×	159 1.8×	104 1.3×	17 0.2×	32 1.8×	14	317

Countries citing papers authored by Daniéla Rusu

Since Specialization

Citations

This map shows the geographic impact of Daniéla Rusu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniéla Rusu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniéla Rusu more than expected).

Fields of papers citing papers by Daniéla Rusu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniéla Rusu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniéla Rusu. The network helps show where Daniéla Rusu may publish in the future.

Co-authorship network of co-authors of Daniéla Rusu

This figure shows the co-authorship network connecting the top 25 collaborators of Daniéla Rusu. A scholar is included among the top collaborators of Daniéla Rusu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniéla Rusu. Daniéla Rusu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Rousseau, Thierry, Ludovic Ferrer, J Lacoste, et al.. (2024). Between Pathological Prostate Cancer Lymph Nodes and Sentinel Nodes. Clinical Nuclear Medicine. 49(11). e532–e537.

Rousseau, Caroline, Olivier Kerdraon, Ludovic Ferrer, et al.. (2024). Pilot Feasibility Study. Clinical Nuclear Medicine. 49(8). 701–708. 3 indexed citations

Rousseau, Caroline, Nicolas Arlicot, L. Campion, et al.. (2022). Pilot study with [¹⁸F]DPA-714 PET-CT to explore tumor-associated-macrophages in triple negative breast cancer.. Journal of Clinical Oncology. 40(16_suppl). e12557–e12557. 1 indexed citations

Ferrer, Ludovic, et al.. (2022). Vaccine-Related Lymph Nodes. Clinical Nuclear Medicine. 47(7). 575–582. 5 indexed citations

Lannes, F., Michaël Baboudjian, A. Ruffion, et al.. (2022). Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate Cancer (The Prospective SENTINELLE Study). The Journal of Urology. 209(2). 364–373. 10 indexed citations

Fleury, Vincent, et al.. (2021). COVID-19 vaccination may cause FDG uptake beyond axillary area. SHILAP Revista de lepidopterología. 5(1). 11–11. 2 indexed citations

Ferrer, Ludovic, Olivier Morel, Daniéla Rusu, et al.. (2020). Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer. Cancers. 12(6). 1512–1512. 5 indexed citations

Rousseau, Caroline, Ludovic Ferrer, Daniéla Rusu, et al.. (2019). Preliminary results of a ⁶⁸Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making. The Prostate. 79(13). 1514–1522. 22 indexed citations

Schlumberger, Martin, Sophie Leboulleux, Bogdan Catargi, et al.. (2018). Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial. The Lancet Diabetes & Endocrinology. 6(8). 618–626. 103 indexed citations

10.

Ferrer, Ludovic, Daniéla Rusu, A. Rauscher, et al.. (2018). 68Ga‐PSMA‐11 PET‐CT study in prostate cancer patients with biochemical recurrence and non‐contributive 18F‐Choline PET‐CT: Impact on therapeutic decision‐making and biomarker changes. The Prostate. 79(5). 454–461. 14 indexed citations

11.

Rusu, Daniéla, et al.. (2018). 68Ga-PSMA PET/CT Urachus Metastases in Recurrent Prostate Cancer With Very Low PSA Level. Clinical Nuclear Medicine. 44(1). 40–41. 4 indexed citations

12.

Leenhardt, Laurence, Sophie Leboulleux, Claire Bournaud, et al.. (2018). Recombinant Thyrotropin vs Levothyroxine Withdrawal in 131I Therapy of N1 Thyroid Cancer: A Large Matched Cohort Study (ThyrNod). The Journal of Clinical Endocrinology & Metabolism. 104(4). 1020–1028. 11 indexed citations

13.

Fleury, Vincent, Ludovic Ferrer, Daniéla Rusu, et al.. (2018). Advantages of systematic trunk SPECT/CT to planar bone scan (PBS) in more than 300 patients with breast or prostate cancer. Oncotarget. 9(60). 31744–31752. 14 indexed citations

14.

Mathieu, Cédric, Ludovic Ferrer, Thomas Carlier, et al.. (2015). Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with 18F-Choline PET/CT in Prostate Cancer. Frontiers in Medicine. 2. 67–67. 7 indexed citations

15.

Rusu, Daniéla, Thomas Carlier, Vincent Fleury, et al.. (2015). Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up. Frontiers in Medicine. 2. 46–46. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact